QL Pharma Reports Ph 2 Results of Zovaglutide Study at EASD 2025
18 Sep 2025 //
PR NEWSWIRE
QL Biopharm Presents Phase 1c Results For Monthly GLP-1RA ZT002 At EASD
12 Sep 2024 //
PR NEWSWIRE
QL Biopharm Announces GLP-1RA Abstract for EASD Annual Meeting 2024
03 Sep 2024 //
PR NEWSWIRE